Attachment 23 - Asbestos Survey - Building T1 - Final Rev 1.pdf

PDF 4 MB Posted

Attached to
687-23-101 CON Repair Exterior Features Federal contract opportunity
Solicitation number
36C26026R0033
Issued by
Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20

About this file

This is an Asbestos Survey Report for Building T1 at the Walla Walla VA Medical Center in Walla Walla, Washington, prepared by Mabbett & Associates, Inc. in June 2019. The survey was conducted under AES Contract Number VA201-1901.1 to identify asbestos-containing materials (ACM) for worker protection and future renovation planning purposes.

The survey involved collection of eighteen (18) bulk samples from suspect materials across the building, with seventeen (17) samples analyzed by polarized light microscopy (PLM) and one (1) positive stop sample. Laboratory analysis identified three (3) homogeneous materials containing asbestos greater than 1%: 12"x12" beige floor tile in Room 105 containing 5% chrysotile (100 square feet), pipe fitting insulation in the crawlspace designated as presumed ACM (12 units), suspect asbestos debris and contaminated soil in the crawlspace (250 square feet), and exterior cement board containing 10% chrysotile (200 square feet). The building, constructed in 1947 as the Complementary and Integrative Health facility, is a one-story structure with concrete foundation and asphalt shingle roof occupying approximately 1,152 square feet. The report notes that survey access was limited to visible areas, and comprehensive pre-demolition inspections must be conducted before any renovation or maintenance activities involving previously inaccessible areas. If ACM will be disturbed, removal must be performed by a licensed asbestos abatement contractor in accordance with applicable regulations.

View the file

Other files for this federal contract opportunity

Other files attached to 687-23-101 CON Repair Exterior Features, newest first.
File Type Posted
36C26026R0033 0009.pdf PDF
36C26026R0033 0008.docx DOCX document
Attachment 10 - RFI Questions P0008.docx DOCX document
Attachment 4 - 687-23-101_100__COMPLETE_DRAWING_SET_VA REDLI.pdf PDF
Attachment 2 - SPECS VOL 1 Rev 1 Less T1 and T2.pdf PDF
Attachment 12 - Asbestos Survey - Building 48 - Final Rev 1.pdf PDF
Attachment 15 - Asbestos Survey - Building 65 - Final Rev 1.pdf PDF
Attachment 22 - Asbestos Survey - Building 120 - Final Rev 1.pdf PDF
Attachment 26 - Exterior Building Lead Condition-Presence-Absence.pdf PDF
Attachment 14 - Asbestos Survey - Building 63 - Final Rev 1.pdf PDF
Attachment 18 - Asbestos Survey - Building 81 - Final Rev 1.pdf PDF
Attachment 24 - Asbestos Survey - Building T2 - Final Rev 1.pdf PDF
Attachment 28 - RFI and Responses 687-23-101.xlsx XLSX spreadsheet
36C26026R0033 0007.pdf PDF
Attachment 10 - Asbestos Survey - Building 31 - Final Rev 1.pdf PDF
Attachment 11 - Asbestos Survey - Building 41 - Final Rev 1.pdf PDF
Attachment 13 - Asbestos Survey - Building 49 - Final Rev 1.pdf PDF
Attachment 16 - Asbestos Survey - Building 66 - Final Rev 1.pdf PDF
Attachment 19 - Asbestos Survey - Building 82 - Final Rev 1.pdf PDF
Attachment 20 - Asbestos Survey - Building 105 - Final Rev 1.pdf PDF
Attachment 21 - Asbestos Survey - Building 107 - Final Rev 1.pdf PDF
Attachment 25 - Asbestos Survey - Building T7 - Final Rev 1.pdf PDF
Attachment 27 - 08 71 00 DOOR HARDWARE.pdf PDF
Attachment 17 - Asbestos Survey - Building 76 - Final Rev 1.pdf PDF
Attachment 29 - Mobilization-Project-Areas.pdf PDF
36C26026R0033 0006.docx DOCX document
Site Visit 2nd Sheet.pdf PDF
36C26026R0033 0005.docx DOCX document
Site Visit Sign-In Sheet - February 9 2026.jpg JPG image
36C26026R0033 0004.docx DOCX document
687-23-101_Repair_Exterior_Features_Geotech Memorandum.pdf PDF
687-23-101- 36C26026R0033 - Contractor Questions and Answers.pdf PDF
36C26026R0033 0003.docx DOCX document
36C26026R0033 0002.docx DOCX document
36C26026R0033 0002 pdf version Rev. 01.pdf PDF
36C26026R0033 0002 pdf version Rev. 01.pdf PDF
36C26026R0033 pdf version.pdf PDF
36C26026R0033 0001.docx DOCX document
Attachment 4 - COMPLETE_DRAWING_SET_VA REDLINES.pdf PDF
Attachment 3 - SPECS VOL 2 687-23-101 Exterior Repairs 01.26.2026.pdf PDF
Attachment 2 - SPECS VOL 1 687-23-101 Exterior Repairs 01.26.2026.pdf PDF
36C26026R0033.docx DOCX document
Attachment 8 - Contractor Rules of Behavior 687-23-101 Repair Exterior Features.pdf PDF
Attachment 7 - PPQ NCO 20 687-23-101.docx DOCX document
Attachment 5 - Divisional Price Breakout.xlsx XLSX spreadsheet
Attachment 9 - Wage Determination 1.23.2026.pdf PDF
Attachment 6 - Limitations on Subcontracting 687-23-101 Repair Exteriors.docx DOCX document
Attachment 1 - SOW CON Repair Exterior Features Rev 01.docx DOCX document
Show all 48

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

RIMA’S TEMPLATE

p

WALLA WALLA VA MEDICAL CENTER

ASBESTOS SURVEY REPORT

BUILDING T1

Mabbett Project No. R2019002.000.001 June 2019

Prepared for:

11031 S. Pikes Peak Drive, Suite 202 Parker, CO 80138 and

Walla Walla VA Medical Center 77 Wainwright Drive Walla Walla, WA 99362

Mabbett & Associates, Inc.

5 Alfred Circle Bedford, MA 01730-2318 T. 781-275-6050 Massachusetts | Virginia | Rhode Island | New Jersey www.mabbett.com

© 2019, Mabbett & Associates, Inc.

BUILDING T1 – ASBESTOS SURVEY REPORT

Walla Walla VA Medical Center | Walla Walla, WA

© 2019, Mabbett & Associates, Inc. i June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg T1\Building T1 Walla Walla VAMC - Final Rev 1.doc

ACKNOWLEDGEMENT

This Asbestos Containing Material (ACM) Survey Report was prepared in accordance with an established scope of work as defined in the Mabbett Proposal No. P2018292 for AES Contract Number VA201-1901.1. The information presented herein is based on the facts and information conveyed to or received by Mabbett & Associates, Inc.

(Mabbett®) during the preparation of this report. If any of the information provided to Mabbett that was used in preparing this report is incorrect, incomplete, or subject to change, Mabbett would wish to alter its opinion(s) accordingly. In addition, the professional opinions and information contained in this report are based solely on the requirements of the applicable regulations and technical data as known to Mabbett as of the date of this report and considered applicable to this report.

This report was prepared by:

Kevin M. Donovan Environmental, Health and Safety Specialist

This report has been reviewed and approved by:

Michael F. Delaney Director, Building Sciences Group

© 2019, Mabbett & Associates, Inc. ii June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg T1\Building T1 Walla Walla VAMC - Final Rev 1.doc

TABLE OF CONTENTS

SECTION PAGE

1.0 INTRODUCTION

2.0 BUILDING DESCRIPTION

3.0 ASBESTOS SURVEY

3.1 Sampling Methodology

3.2 Analytical Methodology

3.3 Summary of Asbestos Containing Materials (ACM) Findings

3.3.1 Drawings

4.0 LIMITATIONS

5.0 CLOSING REMARKS

TABLES

Table 1 – Summary of ACM (in text) Table 2 – Summary of ACM Sampling Results

FIGURES

Figure 1 – Asbestos Survey, Building T1 – First Floor

APPENDICES

Appendix A – Table 2, Summary of ACM Sampling Results Appendix B – Laboratory Analytical Results and Chain of Custody Appendix C – Historical Asbestos Survey Data

© 2019, Mabbett & Associates, Inc. 1 June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg T1\Building T1 Walla Walla VAMC - Final Rev 1.doc

1.0 INTRODUCTION

Mabbett and Associates, Inc. (Mabbett®) performed surveys for suspect asbestos containing materials (ACM) of selected buildings at the Walla Walla VA Medical Center (Walla Walla VAMC) located at 77 Wainwright Drive in Walla Walla, Washington, under AES Contract Number VA201-1901.1. This report presents results of the ACM survey conducted at Building T1. Site survey work was performed over two periods ranging from February 11, 2019 through February 15, 2019 and March 20, 2019 through March 21, 2019, by appropriately credentialed regulated building materials inspectors. Bulk samples of suspected ACM were collected and submitted to a certified analytical laboratory for asbestos analysis by polarized light microscopy (PLM) using stop positive methodology. Confirmatory analysis of some samples by transmission electron microscopy (TEM) was conducted as required. The survey effort involved the collection of the following samples, resulting in the following conclusions:

Eighteen (18) bulk samples for suspect ACM were collected in this building.

Based on laboratory analysis of suspect ACM, one (1) of the collected samples contained asbestos greater than 1%.

Two (2) additional materials were previously sampled and identified as ACM or Presumed ACM (PACM).

The Asbestos Survey was comprised of three primary project tasks including:

Evaluation of previous survey data (if available) and existing site conditions and formulation of the sampling plan.

Site survey to collect building material samples for laboratory analysis and reporting.

Interpretation of laboratory data and development of this Asbestos Survey Report.

This project deliverable is supported by a series of tables and appendices that are embedded within this report, or provided as attachments.

2.0 BUILDING DESCRIPTION

According to information provided by the VAMC and observations made by the Mabbett team at the time of the survey, Building T1 is the Complementary and Integrative health (CHI) Building which is a one-story structure on a concrete foundation with a crawlspace and an asphalt shingle roof. The building was reportedly built in 1947 and occupies approximately 1,152 square feet.

3.0 ASBESTOS SURVEY

3.1 Sampling Methodology

The Mabbett team performed a physical U.S. Environmental Protection Agency (EPA) Asbestos Hazard and Emergency Response Act (AHERA) type inspection and sampling of suspect materials as required by EPA Asbestos Hazard Emergency Response Act (AHERA) regulations (i.e. 40 CFR 763), OSHA Asbestos Standards (i.e. 29 CFR

1910.1001 & 29 CFR 1926.1101) and the VHA Asbestos Management Directive (VHA Directive 7714).

The Walla Walla VAMC provided Mabbett with two historical asbestos inspection reports for asbestos surveys that were previously conducted at the facility. The first survey was conducted by Environmental Health Sciences, Inc. in October 1989. The second survey, which was limited in scope, was conducted by Blue Mountain Environmental & Consulting, Inc. in December 2003. These reports were reviewed by the Mabbett team prior to performing inspection activities. In some instances, ACM identified by the previous surveys was confirmed by Mabbett, reassessed and included in this Asbestos Survey Report.

© 2019, Mabbett & Associates, Inc. 2 June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg T1\Building T1 Walla Walla VAMC - Final Rev 1.doc

A visual screening inspection was conducted to identify locations of suspect ACM throughout identified areas of the building by Asbestos Hazard and Emergency Response Act (AHERA) trained and accredited asbestos inspectors. Only areas that were accessible during the field work phase were inspected. Every effort was made during the initial field survey work to access areas as necessary to complete the survey.

General areas that were inaccessible or where the survey was limited to visual observation only are identified below:

• Within walls • Within fire doors

• Enclosed pipe/duct chases •Inside mechanical equipment/ductwork

• Above fixed drywall or plaster ceilings without access panels

Due to these access restrictions, comprehensive pre-demolition ACM surveys should be performed prior to any proposed renovations or maintenance involving inaccessible areas. Roofing materials were not sampled in order to maintain applicable warranties.

Bulk samples were collected of suspect ACM in accordance with AHERA and conducted according to the following sampling plan:

a) Surfacing material:

a. At least three bulk samples were collected from each homogeneous area that is 1,000 ft2 or less.

b. At least five bulk samples were collected from each homogeneous area that is greater than 1,000 ft2 but less than or equal to 5,000 ft2.

c. At least seven bulk samples were collected from each homogeneous area that is greater than 5,000 ft2.

b) Thermal system insulation:

a. At least three bulk samples were collected from each homogeneous area of thermal system insulation.

b. At least one bulk sample was collected from each homogeneous area of patched area of thermal system insulation.

c. Sufficient samples were collected from elbows and fittings to determine if they contain ACM.

d. Bulk samples were not collected from any homogeneous area where the state licensed asbestos inspector determined that the thermal system insulation is fiberglass, foam glass, rubber, or other non-ACM.

c) Miscellaneous material:

a. At least one bulk sample was collected from each homogeneous area that is less than 100 ft2.

b. At least two bulk samples were collected from each homogeneous area that is greater than 100 ft2.

3.2 Analytical Methodology

The collected bulk samples were submitted under chain of custody procedures to ProScience of Woburn, MA.

ProScience is accredited by the American Industrial Hygiene Association (AIHA) and participates in the National Voluntary Laboratory Accreditation Program (NVLAP Lab Code 200090-0). Bulk samples were analyzed with polarized light microscopy (PLM) using EPA Method 600/R-93/116.

Bulk sample results are summarized in Table 2 – Summary of ACM Sampling Results and included as Appendix A. The

© 2019, Mabbett & Associates, Inc. 3 June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg T1\Building T1 Walla Walla VAMC - Final Rev 1.doc

EPA and the Occupational Safety and Health Administration (OSHA) defines any material that contains greater than one percent (>1%) asbestos as being an ACM. As such, the analytical laboratory identified bulk samples as positive for asbestos that met the regulatory criteria of greater than or equal to one percent (≥1%) asbestos. Laboratory reports and the chain of custodies are provided in Appendix B. Historical asbestos survey data is provided in Appendix C of this report.

3.3 Summary of Asbestos Containing Materials (ACM) Findings

Mabbett sampled nine (9) types of homogenous materials and collected eighteen (18) representative bulk ACM samples. Seventeen (17) samples were analyzed by PLM and one (1) sample was a positive stop and not analyzed.

The current and historical laboratory analytical data indicated that three (3) homogenous material had greater than 1% asbestos and were ACM or PACM. Estimated quantities of materials identified as ACM or PACM are presented in Table 1 below:

Table 1 Summary of ACM

Building T1 Walla Walla VAMC

Sample / Homogeneous

Area No.

Location Description of Material

Percent and Type of

Asbestos

Estimated Quantity Material

Type Condition Amount Units

08 Room 105 12" x 12" Beige Floor Tile (Under Carpet) 5% Chrysotile 100 SF Misc. Covered

NA Crawlspace Pipe Fitting Insulation PACM 12 EA TSI Damaged

NA Crawlspace Suspect Asbestos

Debris and Contaminated Soil

Visual Observation 250 SF Misc. Damaged

NA Exterior Cement Board 10% Chrysotile* 200 SF Misc. Damaged Notes:

SF = Square Feet Misc. = Miscellaneous Material EA = Each TSI = Thermal System Insulation

* = Material Identified as ACM or PACM by Previous Testing

3.3.1 Drawings

The location of each collected bulk sample and its sample ID is shown on the drawings in the Figures Section of this report. Each positive ACM sample location is marked with an asterisk (*), while positive stops are marked with two asterisks (**). Collected bulk samples that were not positive are identified solely by the sample ID.

4.0 LIMITATIONS

This survey report is the result of both a qualitative (visual inspection) and quantitative assessment of potential ACM in Building T1 at the Walla Walla VAMC. Although a comprehensive inspection was performed with the majority of the building accessed for evaluation and sampling purposes, Mabbett does not claim to have identified all of the materials that may be present at/in the facility due to limitations. Only accessible and authorized areas/materials were included in this survey. Mabbett has conducted this assessment with reasonable care and has performed this project within generally accepted industry standards. Mabbett makes no assurances that the information, research, and technology used to prepare this report may not change in the future, thus affecting the results reported herein.

© 2019, Mabbett & Associates, Inc. 4 June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg T1\Building T1 Walla Walla VAMC - Final Rev 1.doc

5.0 CLOSING REMARKS

Prior to initiating plans for maintenance activities, the Walla Walla VAMC should review the asbestos survey results to determine whether any of the materials identified as ACM will be disturbed by proposed work activities. This report may not be used as a renovation/demolition Asbestos National Emission Standards for Hazardous Air Pollutants (NESHAP) type inspection report. Prior to any renovation/demolition activities, a full destructive asbestos inspection of the work area, including any previously inaccessible or unsampled materials that might be impacted, must be conducted.

The purpose of this ACM survey was to identify ACM in Building T1 within the limitations of the survey for worker protection purposes and for future renovation planning. In regard to asbestos, any suspect material encountered during maintenance activities that is not identified in this report as being non-ACM should be assumed to be ACM unless laboratory analytical data for bulk samples prove otherwise. Suspect ACM that may be present within the walls, above inaccessible hard ceilings, or in other inaccessible locations, and that accordingly was not inspected, should be assumed to contain asbestos if discovered until otherwise verified, as previously described. If ACM will be disturbed, the ACM must be removed by a licensed asbestos abatement contractor and be performed in accordance with applicable regulations. If proposed work activities will not disturb intact ACM, continuous monitoring of ACM should be conducted throughout work activities to ensure the ACM remains in an intact condition. Additionally, prior to commencing work activities, all personnel involved should be made aware of the location of known ACM within the building in which they will be working.

© 2019, Mabbett & Associates, Inc. FIGURES June 2019 Project No. R2019002.000.001 Building T1 Walla Walla VAMC - Final Rev 1.doc

FIGURES

T1-07A T1-07B

T1-06A

T1-01A T1-01B

T1-02A T1-02B

T1-03A T1-03B

T1-04A T1-04B

T1-06B T1-08A* T1-08B**

T1-09A T1-09B

T1-05A

T1-05B

PROJECT NUMBER

BUILDING NUMBER

DRAWING NUMBER

PROJECT TITLE

LOCATION

ISSUE DATE CHECKED DRAWN

DRAWING TITLE

VA FORM 08 - 6231

A

F i l e

P a t h

Office of

Construction and Facilities

Management

U.S. Department of Veterans Affairs

B

C

D

E

F

A

B

C

D

E

F

21 4 5 6 7 8 9 10

PHASE:

ARCHITECT/ENGINEER OF RECORD

SEAL

CONSULTANT

321 4 5 6 7 8 9 10

COMPREHENSIVE BASELINE

ASBESTOS SURVEY

WALLA WALLA, WA

687-19-105 AE

APPROVED: PROJECT DIRECTOR

JUNE, 2019

REVISIONS: DATE:

Group, Inc.

11031 SOUTH PIKES PEAK DRIVE #202

PARKER, COLORADO 80138

PH: 303.841.3922

WWW.AES-GRP.COM

RECORD DRAWINGS

DWG. OF

GENERAL NOTES:

1. DRAWINGS DO NOT CLAIM TO IDENTIFY ASBESTOS CONTAINING MATERIAL

PRESENT IN THE BUILDING AND SHOULD NOT BE THE BASIS FOR IDENTIFYING

ACM FOR FUTURE RENOVATION OR DEMOLITION PROJECTS, ABATEMENT

SPECIFICATIONS, ETC. THIS SURVEY DOES NOT MEET THE REQUIREMENTS OF A

PRE-RENOVATION NESHAP SURVEY. MABBETT'S SURVEY WAS PERFORMED

WITH LIMITATIONS INHERENT TO NON-DESTRUCTIVE VISUAL INSPECTIONS IN

OCCUPIED SPACES. ANY SUSPECT MATERIAL ENCOUNTERED DURING

RENOVATION/DEMOLITION THAT IS NOT IDENTIFIED AS BEING NON-ACM SHOULD

BE ASSUMED TO BE ACM UNLESS SAMPLE RESULTS PROVE OTHERWISE.

LEGEND:

1,2

25*

25(TEM)

25**

APPROXIMATE SAMPLE LOCATION

SAMPLE GREATER THAN 1% ASBESTOS

SAMPLE GREATER THAN 1% ASBESTOS (TEM)

STOP POSITIVE SAMPLE FOR ASBESTOS

NO ASBESTOS DETECTED (NAD)

BUILDING T-1

GROUND FLOOR

T1-101

T-1

WBRMFD

0'

SCALE: 1/4" = 1'-0"

8'4'2'

AutoCAD SHX Text

CORRIDOR

AutoCAD SHX Text

FUNCTION

AutoCAD SHX Text

AGENT CASHIER

AutoCAD SHX Text

ACCOUNTING/PAYROLL

AutoCAD SHX Text

ASST. CHIEF FISCAL

AutoCAD SHX Text

CHIEF FISCAL

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text

BUILDING - T-1

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text

ROOM#

AutoCAD SHX Text

FOYER

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text

AutoCAD SHX Text N

© 2019, Mabbett & Associates, Inc. APPENDIX A June 2019

’S TEMPLATE

APPENDIX A

Table 2 Summary of ACM Sampling Results

© 2019, Mabbett & Associates, Inc. Appendix A Page 1 of 1 June 2019

Table 2

Summary of ACM Sampling Results Building T1

Walla Walla VAMC Sample

No. Sample Location Description of Material Percent and Type of Asbestos

T1-01A Room 101 2' x 2' Ceiling Tile White Small & Large Fissure NAD

T1-01B Room 101 2' x 2' Ceiling Tile White Small & Large Fissure NAD

T1-02A Room 101 12" x 12" Ceiling Tile White Pin Holes and Small Fissures NAD

T1-02B Room 101 12" x 12" Ceiling Tile White Pin Holes and Small Fissures NAD

T1-03A Room 101 12" x 12" Ceiling Tile White Deep Fissures NAD

T1-03B Room 101 12" x 12" Ceiling Tile White Deep Fissures NAD

T1-04A Room 101 Brown Ceiling Tile Adhesive NAD T1-04B Room 101 Brown Ceiling Tile Adhesive NAD

T1-05A Room 104 2' x 2' White Ceiling Tile Pin Hole and Fissures NAD

T1-05B Room 102 2' x 2' White Ceiling Tile Pin Hole and Fissures NAD

T1-06A Room 103 White Gypsum Wallboard NAD T1-06B Room 102 White Gypsum Wallboard NAD T1-07A Room 103 White Joint Compound NAD T1-07B Room 103 White Joint Compound NAD T1-08A Room 105 12" x 12" Beige Floor Tile 5% Chrysotile T1-08B Room 105 12" x 12" Beige Floor Tile NA/PS T1-09A Room 105 Black Floor Tile Mastic NAD T1-09B Room 105 Black Floor Tile Mastic NAD Notes:

NAD = No Asbestos Detected NA/PS = Not Analyzed / Positive Stop

© 2019, Mabbett & Associates, Inc. APPENDIX B June 2019

APPENDIX B

Laboratory Analytical Results and Chain of Custody

© 2019, Mabbett & Associates, Inc. APPENDIX C June 2019

APPENDIX C

Historical Asbestos Survey Data

1.0 INTRODUCTION
2.0 BUILDING DESCRIPTION
3.0 ASBESTOS SURVEY
3.1 Sampling Methodology
3.2 Analytical Methodology
3.3 Summary of Asbestos Containing Materials (ACM) Findings
3.3.1 Drawings
4.0 LIMITATIONS
5.0 CLOSING REMARKS
Figure 1 - BT1 June.pdf
Sheets and Views
VAWA BUILDING T-1 - 1ST FLOOR-Layout1

File details come from the government source that posted it. Updated .